TipRanks
Go Ultimate55% OFF

Polly A. Murphy Insider Profile

4 Followers

Polly A. Murphy, Director at Atea Pharmaceuticals, holds 121.75K shares in Atea Pharmaceuticals (Ticker: AVIR), holds 6.53K shares in Celcuity (Ticker: CELC).

Polly A. Murphy's Trading History

AVIR
Atea Pharmaceuticals
Jun 23, 2026DirectorUninformative Buy129.06K$500.37K
CELC
Celcuity
Jun 09, 2026DirectorUninformative Buy―$451.42K

You May Also Like

Polly A. Murphy insider profile FAQ

What is the percentage of profitable transactions made by Polly A. Murphy?
The percentage of profitable transactions made by Polly A. Murphy is 33%.
What is the average return per transaction made by Polly A. Murphy?
The average return per transaction made by Polly A. Murphy is -1.40%.
What stocks does Polly A. Murphy hold?
Polly A. Murphy holds: AVIR, CELC stocks.
What was Polly A. Murphy’s latest transaction?
Polly A. Murphy’s latest transaction was an Uninformative Buy of $129.06K.
What was Polly A. Murphy's most profitable transaction?
Polly A. Murphy’s most profitable transaction was an Informative Buy of CELC stock on November 23, 2022. The return on the trade was 44.00%.
What is Polly A. Murphy's role in Atea Pharmaceuticals?
Polly A. Murphy's role in Atea Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.